Pacer Advisors, Inc. Cytokinetics Inc Transaction History
Pacer Advisors, Inc.
- $40.5 Billion
- Q4 2024
A detailed history of Pacer Advisors, Inc. transactions in Cytokinetics Inc stock. As of the latest transaction made, Pacer Advisors, Inc. holds 24,843 shares of CYTK stock, worth $942,294. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,843
Previous 24,153
2.86%
Holding current value
$942,294
Previous $1.28 Million
8.39%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CYTK
# of Institutions
400Shares Held
115MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$557 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$452 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$408 Million0.31% of portfolio
-
State Street Corp Boston, MA6.17MShares$234 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.84MShares$108 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.57B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...